Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"Previously exclusively used in research, Hasomed’s Rehastim2 FES integration with Ekso is now available for routine clinical use in registered CE marked countries."
https://eksobionics.com/eksohealth/hasomed-partnership/
I was going to talk about the pilot, but this is a bigger deal from my perspective.
Knowing this, it makes much more sense to me why Ekso is getting into post-acute centers now versus prior. I wonder when this was launched or why no one is talking about it? FES really sets Ekso apart in a big way.
I think Ekso's lead w/ FES is going to be the dominating factor for the company short term. Look at what it made possible with Mark Pollock
https://newsroom.ucla.edu/releases/completely-paralyzed-man-voluntarily-moves-his-legs-ucla-scientists-report
It begs the question: Is Ekso Bionics poised to cure paralysis?
Ottobock version of Ekso Vest:
Feb 27, 2020 • 4:30pm EST
https://ir.eksobionics.com/ir-calendar
"Transformation of Paralysis to Stepping" upcoming study sponsored by University of Louisville w/ Alexander Ovechkin.
15 participants over 5 year period, not yet recruiting.
https://clinicaltrials.gov/ct2/show/NCT04105114?term=Ekso+Bionics&draw=2&rank=8
I'd also point out this past story in relation:
https://newsroom.ucla.edu/releases/completely-paralyzed-man-voluntarily-moves-his-legs-ucla-scientists-report
I wonder what the purpose of the Buspar is
What this last press release means to me is that there's probably a growing number of patients asking about rehabilitation exoskeletons - patients who are beginning to expect exoskeletons as a standard of care. I think this is really a big overlooked factor when it comes to Ekso. I'd posit there is probably a critical threshold of exoskeleton usage that once passed will rapidly speed up further adoption and sales.
Reading this from 3 EksoNR sales is perhaps a bit of a stretch, but it's very positive to see the company talk about network healthcare centers and multi-unit purchases and then have that come into reality quite quickly; hopefully this trend continues. I'm quite happy with the company's recent moves. Every press release with the phrase "the most clinically used robotic exoskeleton." is a good one I'd say.
Here's a search of all of Ekso's Clinical Trials - worth noting a FES trial actively recruiting:
https://clinicaltrials.gov/ct2/results?cond=&term=Ekso+Bionics&cntry=&state=&city=&dist=
I'm long EKSO
We know the revenue estimate, but not expenses or EPS.
Q4 2019 coming up fast
Another competitor: https://www.roamrobotics.com
Interesting to see they're going actively attempting to go into the sports market via skiing for their first product.
They seem to have good marketing, but I'd like to see technical specs.
I'm long EKSO
“Using electrical stimulation of the spinal cord, a number of subjects had been able to stand and regain some movement and feeling — and most importantly, to regain some of the body’s internal functions that are designed to keep us alive and to make that life a pleasure,” George says. “Electrical stimulation of the spinal cord, we think, is the first meaningful therapy ever for paralyzed people.”
http://newsroom.ucla.edu/releases/completely-paralyzed-man-voluntarily-moves-his-legs-ucla-scientists-report
Quote Source: http://newsroom.ucla.edu/stories/ucla-scientist-helps-couple-find-hope-while-searching-for-a-cure-for-paralysis
The reason I'm so excited by the FES trial is that I think it will amplify the current reasons Ekso can outshine the field.
My understanding is that Ekso GT senses and responds about 500 times a second to motion and trajectory information. I don't know that many other exoskeleton competitors can say the same.
Anyhow, it may well be that FES stimulation AND exoskeleton responses need to occur on a similar timescale in order to be most effective working together. I'm certainly not an expert in this field, but I do know enough anatomy/physiology to know that nerves absolutely fire at these kinds of frequencies. Specifically: Each neurons fires (on average) about 200 times per second. I don't know if there is a definitive answer to this, but it may well be this very study that gives an answer.
I also vaguely remember reading in the Ekso patents some novel articulation technology Ekso created to be able to rapidly switch between phases of mechanical resistance/passive/support. It seems likely to me that this will give Ekso both a software and hardware advantage for incorporating FES.
Putting all these things together, if Ekso can produce the first exoskeleton to get FDA FES clearance - it could really be a game changer. With a finishing date later this year, I'm very excited to see results.
I'm long EKSO
FES CLINICAL TRIAL!!! Collaborator: U.S. Department of Education
Now enrolling. https://clinicaltrials.gov/ct2/show/NCT04250688
A collaborator is an organization other than the Sponsor that provides support for a clinical study. This support may include funding, design, implementation, data analysis, or reporting. (See also Collaborators data element on ClinicalTrials.gov.)
https://clinicaltrials.gov/ct2/help/glossary/collaborator
Sponsor:
Shirley Ryan AbilityLab
https://www.sralab.org/researchers/arun-jayaraman-pt-phd
---
Also, see this relevant, but older release https://ir.eksobionics.com/press-releases/detail/633/ekso-bionics-partners-with-hasomed-to-launch-functional
---
last note:
Actual Study Start Date : January 1, 2016
Estimated Primary Completion Date : May 31, 2020
yet
First Posted : January 31, 2020
does this make sense, why it was only posted so close to its completion date? Probably a good reason for this, but I'm not an expert on clinical trials
https://clinicaltrials.gov/ct2/show/NCT04250688
Who else has positive EPS, listed on NASDAQ/NYSE?
I bought 4200 more shares today, will buy more if it continues to fall
The last few q's there has been strong revenue growth and cost cutting, but the stock has yet to really react.
Sort of unheard of to have a public exoskeleton-only company that is actually making a profit.
I do expect to do very well in Ekso
I like the optimism of the R-S not happening, but I'd be curious to know the odds of penny stocks on the NASDAQ recovering from under $.50 with out an R-S. I would guess it would be slim, but I do not know.
A little dilution isn't the end of the world, if the company is headed in the right direction long term
I sold a chunk today, but I'm holding shares through the R-S too
You hate to see it, but I think we all thought it was likely to come soon. I suspect shareholders will approve
Overdue for a correction in my opinion
Doubled my share count in EKSO today, holding long
I have a good feeling about the NR gaining traction. I think a large-scale medical contract gets ever more likely as revenue numbers continue to ramp. It feels like Ekso NR is a generation ahead of its medical rehabilitation competitors. It also anecdotally feels like fewer never before seen medical exoskeletons are being produced, with a shift toward industrial prototypes. On a psychological level, it seems like Ekso and rehabilitation exoskeletons are becoming normalized to people as this happens.
Based on the prereporting, it seems likely that now the share price is near its all time low while revenues are at their all time high. This differential between fundamentals and market timing is highly appealing to me as a value proposition.
Held Positions 17 21,957,706
Pretty sure this is the more important line, at least with the proportions. lol
Was the recent string of acquisitions was based off performance metrics, timing, or something else? I don't know the answer to this, does anyone else have insight here?
Could easily be that once certain benchmarks get passed, everyone gets granted options to acquire. Anyone have more info on this?
According to WSJ, Ekso Bionics Holdings Inc. (EKSO) obtained an estimated Buy proposal from the 3 brokerage firms currently keeping a deep eye on the stock performance as compares to its rivals. 0 equity research analysts rated the shares with a selling strategy, 0 gave a hold approach, 3 gave a purchase tip, 0 gave the firm a overweight advice and 0 put the stock under the underweight category. The average price goal of one year between several banks and credit unions that last year discussed the stock is $1.43.
Source: https://bovnews.com/2020/01/21/the-best-stocks-to-buy-ekso-bionics-holdings-inc-ekso-and-the-meet-group-inc-meet/
I'm confident these don't infringe Ekso's patents. Oftentimes companies won't even infringe pending patents on the chance they get approved. If you think about it, this would mean a lot of r&d, wasted time, and getting sued by the patent holder if they keep selling post approval.
That said, I'm sure we will see many competing vest products. I think the way Ekso will outshine these is through their soft-exoskeleton components and durability/comfort. Anyone can throw together some springs, but making it comfortable through a smart distribution of load is very complicated. The durability/strength of the articulations and how well articulated the vest is another huge point of difference; essentially range of motion.
So far, most of the competing vest products won't even tell you how much they weigh or lift. Not only do they generally not even list the information, but they won't tell you if you email to ask either (or at least this was anecdotally true for me reaching out to one other company).
If all of these components can be done just right, I think the EksoVest will sort of become akin to a really expensive backpack for the military. Maybe this is an oversimplification, but backpacks are long overdue for an upgrade imo.
EksoVest lifts nearly three times as much, with better weight-to-performance ratios.
I'm seeing your linked exo lifts ~12.12 lbs, EksoVest lifts 30 lbs
Meanwhile, the weights of the vests are more similar
Compare ~5.51lbs to EksoVest's ~9.5lb
Seems like carrying more to get less if you just look at the ratios, although use-cases matter tremendously
I'll believe the price estimates when the product hits the shelves, which Ekso has already done.
My own personal opinion is that other exoskeleton makers aren't learning their lessons. Modern strategies suggest to me that it is better to launch an expensive product and scale up while the product loses some expensive features than to make something with low functionality that doesn't have room for necessary sacrifices for scaling. Tesla is a great example of this. I worry these exoskeleton announcements are more about PR and less about functionality for some companies.
Samsung is working on a rehab exoskeleton of sorts, but it looks pretty minimalist - no quantifiable amount of force is explained.
In the scheme of things it probably doesn't matter much and you're most likely right, but there's a tiny bit of grey space within the semantics.
At the end of the day, the next 10-Q will be of much more import than the interview.
Yes, good news. Meanwhile 52 wk lows and Nasdaq 180 day deadline on price minimum is approaching and a reverse-split is more likely than ever. (Does anyone know the requirements to get a 180 day extension?)
I'll be using the disparity between market/exchange timing and the good fundamental news the company has been having to add small buys.
A very strong next Q could possibly turn this all around. Still, a r-s seems to be in the cards if nothing big happens. I'm planning to buy some more after the fallout on that.
and still more at .37
I entered a new position at .39 - feeling strong about it
I'm long EKSO
He says 'there are still some parts that are classified' -- so it's fairly ambiguous what that means. He could have said 'military work has totally ended' which would be a much different statement.
Still no info on Ekso UE? Pictures at least?
I think the expansion of sales territories to Norden might be indicative of a positive sale trend in the U.S.
Hard to extrapolate internationally, but for me it raises my hopes for the industrial vest sales for Q4.
If further price reductions are coupled with good sales and upgrades to the Ekso NR -- it could be a big next Q (maybe even big enough to hold off R-S)
I'm long EKSO
I agree. I think Ekso is at the cusp of becoming a much larger company
Absolutely. The better and simpler products that Ekso has created, for instance their Ekso Vest, leverage the knowledge of their advanced and more expensive products. Essentially, each of Ekso's previous products has served as basic research to make Ekso Vest possible. I've seen a good number of upper body only type vests from other companies, but nobody seems eager to say exactly how much it lifts, how much it costs, and how heavy it is other than Ekso Bionics. The Ekso Vest lifts up to 30lbs and weighs 9.5lbs, costing around $4,000-$7,000 depending on general use to worker-specific use. Find me a company that exceeds on these metrics (while being a durable, unpowered product) and I'll rethink my stance on Ekso.
Here's a specific example. Ekso moved into the industrial sector with an upper body suit, but are now leveraging much of that same technology for upper body rehabilitation products in the healthcare space.
I also think there's big value in Ekso's patents. I'm excited to learn more about their soft/flexible exoskeleton products in the pipeline.
https://ir.eksobionics.com/press-releases/detail/665
Distribution to Northern Europe for Ekso Vest --
https://ir.eksobionics.com/press-releases/detail/673
I bought more at .40 -- timing is a bit scary with a possible r/s looming that might bring prices down even more, but hey no risk no reward.
Company is in a rapidly growing industry, with products that are getting better and less expensive. Lots trends are in Ekso's favor.
Bought a few hundred shares at limit of .42, I will buy more if it falls lower
I'm long EKSO
What ever happened with Artemis?
https://ir.eksobionics.com/press-releases/detail/616
That Vimeo link is great new interview with Zach Haas, the head of business development at Ekso Bionics.
What's really interesting is the question about military work.
He says "There are pieces of it that are still classified"
But then goes on to say "those are projects we aren't working on anymore"
Here's my take on that ambiguous answer: There could easily be new projects that weren't talked about before that the company is currently working on. On the flip side, maybe their work has completed, but some of the patents (that might not even help their commercial success) are still classified. This would mean there's not really as much to hope for in terms of future military contracts or opportunities.
So -- it's somewhere in the middle. As someone who is optimistic about the company and as someone who follows DARPA much more closely than the average person: I'd like to believe the middle of the road answer actually leans towards more military involvement than apparent for this reason: I don't see other exoskeleton companies that would be overtaking EKSO in the military space and I know how much exoskeletons are a military priority, so I'm cautiously optimistic about this.
At the end of the day, he didn't say 'we're not involved in military work anymore' and instead dropped the 'it's classified' response.